In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A ...

New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...

Recent developments of interest in cardiovascular medicine ...

There is a well-established association between hospitals performing higher volumes of percutaneous coronary intervention (PCI) and improved patient outcomes. However, a new study reveals that the ...

Randomised, double-blind, placebo-controlled, multicentre ORBITA-2 trial. 301 participants with stable angina and evidence of ischaemia had antianginal medications withheld for 2 weeks. They were ...

MANILA, Philippines — A study found that smokers recovering from major heart procedure may face a lower risk of further cardiovascular complications if they switch to e-cigarettes such as vapes rather ...

A new study could change the treatment course for hundreds of thousands of patients, saving lives and preventing complications. Bivalirudin is a safer and more effective anticoagulant than heparin for ...

TCT 1802: Use of a Novel Percutaneous Collapsable 22F-to-10F Mechanical Circulatory Support Device During a High-Risk Percutaneous Coronary Intervention (HRPCI): A Case Report on Ventriculo-Arterial ...